Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
New Speakers Confirmed from Allergan, Genentech, Endo Pharmaceuticals and Parexel at SMi's 2nd Annual Lyophilization USA Conference
Due to four new speakers being added onto the agenda, SMi Group are delighted to announce that a new brochure has been released for the 2nd annual Lyophilization USA conference taking place on April 27th and 28th in Iselin, New Jersey. Those who have recently confirmed to present include Allergan, Genentech, Endo Pharmaceuticals and Parexel. - January 30, 2016 - SAE Media Group
Pushing Collaboration and Financial Incentives in the Global Fight Against Superbugs
Incentives to push antibiotic drug development to be the focus of SMi's 18th annual Superbugs & Superdrugs summit. - January 30, 2016 - SAE Media Group
The Practicalities of Targeted Cell Delivery: Senior Scientists Gather in London to Explore the Latest in RNA Therapeutics
SMi will open its doors to host RNA Therapeutics 2016 in just a few weeks’ time on 15th and 16th February in Central London. - January 30, 2016 - SAE Media Group
Pharma Gets Ready for a Unified Patent Court and Unitary Patent Laws
SMi Training are delighted to introduce its forthcoming workshop taking place on 6th April in Central London: “Getting Read for the UPC and the Unitary Patent – The Do’s and Don’ts in Pharma.” - January 26, 2016 - SAE Media Group
SMi's ADC Summit 2016 to Highlight the Developments for Next Wave of Antibody-Drug Conjugates
SMi Group reports (2016.21.01): Registration now live for the 5th annual ADC Summit taking place at the Holiday Inn Kensington Forum, London, UK on the 23rd – 24th May 2016. - January 24, 2016 - SAE Media Group
Registration Now Open for the 10th Annual Clinical Trial Logistics Conference and Exhibition
SMi Group reports (2016.01.20 – London, UK): Registration is now live for the 10th annual Clinical Trial Logistics Conference and Exhibition on 23-24 May at the Holiday Inn Kensington Forum, London, UK - January 23, 2016 - SAE Media Group
FDA Finally Speeds Up Approval for Ovarian Cancer Drugs
The headline “FDA Regulator, Widowed by Cancer, Helps Speed Drug Approval” has created quite a buzz across the world. The article, published in The New York Times earlier this year, said that the death of Dr Richard Pazdur’s wife, Mary, who battled ovarian cancer for three years,... - January 22, 2016 - Allied Market Research
IQ4I Research & Consultancy Published a New Report on “Drug Discovery Outsourcing (DDO) Global Market”: Estimated to be Worth $29.0 Billion in 2022
IQ4I Research & Consultancy published a new report on “Drug Discovery Outsourcing (DDO) Global Market – Forecast To 2022” which analyzes and studies the major competition, market drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and Rest of the World, spread through 182 slide. - January 14, 2016 - IQ4I Research & Consultancy Pvt. Ltd.
Drug Safety Company Expands Operations
Drug Safety Navigator, LLC (DSN) Announces Another Expansion in Its Fifth Year of Operation - January 13, 2016 - Drug Safety Navigator, LLC
Network with Leading Drug Delivery Experts from Around the World at SMi’s Pre-Filled Syringes 2016
SMi Reports: SMi’s 8th Annual Conference and Exhibition on Pre-Filled Syringes will take place in less than 2 weeks’ time on the 27th-28th January 2016 in London. - January 13, 2016 - SAE Media Group
Rx Partnership Receives $10,000 Critical Community Needs Grant from Dominion to Support Medication Access at Northern Neck Free Health Clinic
Grant will be used to provide the equivalent of $14.3M in prescription medications. - January 07, 2016 - Rx Partnership
Now More Hope for Menopausal Women Experiencing the Physical and Emotional Impact of Painful Sex and Vaginal Dryness
New clinical data released on Prasterone (DHEA) Vaginal Ovules' positive effect on moderate to severe dyspareunia (Painful sex due to menopause) and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. - January 06, 2016 - Endoceutics
H2Biologics Licenses Worldwide, Exclusive Rights to Develop SD1-Granzyme B Drug Conjugate for Treatment of Mesothelin-Expressing Tumors
H2Biologics announced that it has been granted a worldwide, exclusive license by the Research Development Foundation (RDF) for the use of human granzyme B (GrB), a naturally occurring serine protease, in developing an immunoconjugate with a human single domain antibody (SD1) that targets... - December 31, 2015 - H2Biologics Inc.
Arlington Free Clinic Hosts Senator Adam Ebbin and Rx Partnership Board of Directors
State Senator Adam Ebbin (D-30th) and Rx Partnership’s Board of Directors toured the Arlington Free Clinic (AFC) on December 4 during the board’s quarterly meeting. Senator Ebbin and board members were able to learn about the clinic’s daily operations, challenges the clinic faces... - December 30, 2015 - Rx Partnership
National Benefit Builders, Inc. (NBBI) Reaches $750,000,000.00 in Confirmed Savings Through It's Americas Drug Card Program
National Benefit Builders has saved consumers $750,000,000 through it's discount prescription program. - December 21, 2015 - National Benefit Builders, Inc.
Austria Flow Cytometry Market Would be Worth $27.7 Million, by 2020
A new report published by Allied Market Research, titled, "Austria Flow Cytometry Market - Opportunities and Forecast, 2014-2020," predicts the Austria flow cytometry market to reach $27.7 million by 2020. - December 17, 2015 - Allied Market Research
VIRUN NutraBIOsciences Collaborates with Otwo Biotech Shenzhen; 6 New Patent Applications in 2015; Virun’s New Facility is High-Tech; New Webinar Takes a Look Inside
VIRUN continues its’ interstellar growth by working with Chinese company Otwo Biotech of Shenzhen to bring new highly concentrated EPA DHA Omega products to market. Six new patent applications added to an already robust holdings. Virun’s new facility in Pomona, CA. nears completion and boasts State of the Art, eco-friendly functionalism, that includes heightened spray drying capabilities. A Live, upcoming Webinar, Feb. 2016, showcasing an "Inside Look" into VIRUN manufacturing and R&D. - December 16, 2015 - VIRUN
Instant Payment Processing Integrated with Sales Tools, All in One App
If you’re ready to simplify sales execution, boost performance and improve payment agility, then help is at hand with Salesfactor MPOS a bold new way to work with a simple but powerful app. - December 11, 2015 - Leapfactor
ADDCO Publishes Guidelines for Medical Professionals When Recommending a Discount Prescription Card
ADDCO has created guidelines that serve as a standard that doctors can reference and use. Doctors get inundated with different discount prescription cards everyday. Some are very good, many are not. ADDCO's goal is to help the doctors choose. - December 09, 2015 - ADDCO
Recursion Pharmaceuticals Receives $2.6 Million in Follow-on Seed Funding
Funding will be used to accelerate and scale the company’s proprietary drug discovery platform. - December 08, 2015 - Recursion Pharmaceuticals
Florian M. Ward, Ph.D. Recognized as a Professional of the Year by Strathmore's Who's Who Worldwide Publication
Florian M. Ward, Ph.D. of Bel Air, Maryland has been recognized as a Professional of the Year in 2015 by Strathmore’s Who’s Who Worldwide for her outstanding contributions and achievements in the fields of consulting and inventing. About Florian M. Ward, Ph.D. Dr. Ward has over 20... - December 08, 2015 - Strathmore Worldwide
SMI Group Partnered with Visibility Magazine, Announces 8 Influential Insights on Effective Social Media Campaigns in Big Pharma
SMi's 5th annual conference on Social Media in the Pharmaceutical Industry taking place next January in London, will aim to deliver an effective digital toolkit of ideas to implement innovative social media campaigns in a traditional pharma market. - December 07, 2015 - topseos.com
NuvOx Pharma Receives FDA Orphan Drug Designation for Radiosensitizer for Glioblastoma
Tucson based pharmaceutical company NuvOx Pharma announced today that it has secured orphan drug designation from the FDA for its investigational drug NVX-108 for treatment of Glioblastoma. Orphan status provides NuvOx with development and commercial incentives such as tax credits for qualified clinical testing and market exclusivity for 7 years after the marketing approval is granted. - December 07, 2015 - NuvOx Therapeutics
European Pre-Filled Syringes Market: Latest Updates from Allergan, Novartis, MHRA, Sanofi R&D, Amgen, GSK, Sandoz
SMi Reports: SMi’s 8th Annual Conference and Exhibition on Pre-Filled Syringes plays host to key expert speakers from Sanofi R&D, F.Hoffmann-La Rochd Ltd., Amgen and Barts Health Pharmaceuticals. - December 02, 2015 - SAE Media Group
Verix Announces Druglauncher.com, the Aggregated Website of Reference for Pharma Commercial Operations Professionals Launching New Drugs
Verix Inc., a market leader offering solutions for optimizing commercial effectiveness for the Life Sciences market today, announced the release of druglauncher.com, the web site of reference for commercial operations teams launching new drugs. Druglauncher.com will provide insights on best used... - December 01, 2015 - Verix
MedsText.com is Now Live - They Are the Industry Leader in Medication Text Reminders. Forget to Take a Daily Medication? They Can Help.
270 million people in the USA take at least one daily medication. 70% of those do not take them as prescribed by their doctor, according to a Huffington Post article, dated 2013. MedsText is the premier provider for medication text reminders. - November 22, 2015 - MedsText
BUHLMANN Laboratories Announces New, Direct US Affiliate
BÜHLMANN Laboratories is proud to announce the establishment of its North American affiliate, BUHLMANN Diagnostics Corp (BDC) in Southern New Hampshire. - November 16, 2015 - BUHLMANN Diagnostics Corp
Rite Aid First U.S. Drugstore Chain to Offer Harmonyx Genetic Testing to Customers
Tests help determine most effective medication therapy based on an individual’s genetic makeup - November 12, 2015 - Harmonyx Diagnostics
Visibility Magazine Partnered with SMI Group, Announces: Cutting Edge Digital Strategy Discussed by Leading Pharmaceutical Marketing Practitioners
Online Industry Gathers in Two Weeks for 8th Annual Congress on Social Media in the Pharmaceutical Industry - November 12, 2015 - topseos.com
New Acid Catalyst Offers Significant Cost Reductions with Increased Stability
An exciting new acid catalyst from PhosphonicS could help significantly reduce costs and minimise losses in the Pharmaceutical and Chemical industries. The recently launched Phos-Cat4 has been specially designed to be just as effective as the rest of the PhosphonicS acid catalyst range but offer... - November 12, 2015 - PhosphonicS
Preliminary List of Attendees Released for Cold Chain Distribution 2015
SMi have released the preliminary list of attendees for the 10th annual Cold Chain Distribution Conference and Exhibition being held on 3rd – 4th December in London. - November 12, 2015 - SAE Media Group
Clinigen Group and United Therapeutics Initiate Managed Access Program for UNITUXIN™ (Dinutuximab) Injection for High Risk Neuroblastoma
Clinigen Group plc’s (AIM: CLIN, ‘Clinigen’ or the ‘Group’) Idis Managed Access (MA) division and United Therapeutics Corporation (‘United Therapeutics’), a biotechnology company focused on the development and commercialization of products for chronic and... - November 06, 2015 - Clinigen Group
Cold Chain Distribution 2015: SMi Releases Exclusive Interviews with World Courier, Sanofi Genzyme and American Airlines Cargo
SMi Reports (2015.11.03, London): SMi caught up with the key speakers for Cold Chain Distribution 2015 for exclusive interviews ahead of the conference. - November 05, 2015 - SAE Media Group
Compounding Pharmacies Market to Grow at a CAGR of 5.7% Between 2015 and 2021; Future Market Insights
Future Market Insights has announced the addition of the "Compounding Pharmacies Market: U.S. Industry Assessment and Forecast; 2015–2021" report to their offering. - November 04, 2015 - Future Market Insights
New GCP Training with Certificate from Pharma Lessons
The long awaited certificate GCP training course from Pharma Lessons is finally out. It is a beautifully designed online package put together by a team of renowned pharma industry experts. - October 31, 2015 - Pharma Lessons
Tabula Rasa HealthCare Responds to CMS Announcement of Part D Enhanced Medication Therapy Managment Model
Under the CMS Enhanced MTM Model, the personalized MTM services offered by Tabula Rasa HealthCare are now eligible for reimbursement by CMS, and for additional performance-based payments. TRHC's Medication Risk Mitigation Matrix(TM) has proven to reduce adverse drug reactions. - October 29, 2015 - Tabula Rasa HealthCare
Clinical Trials in Russia. The Third Quarter 2015.
The Ministry of Health of the Russian Federation approved 203 new clinical trials of all types, including local and bioequivalence studies, during the 3rd Quarter of 2015. This represents a 13% increase over the same period of last year. - October 25, 2015 - Synergy Research Group
Registration Now Live for SMi’s 10th annual Parallel Trade Conference
SMi Group Reports (23.10.2015): SMi proudly presents its 10th annual conference on Parallel Trade held in London on the 8th to the 9th February 2016. - October 25, 2015 - SAE Media Group
Genzyme and Novartis Pharma to Unveil the Challenges of Pharma Distribution in Emerging Markets and Extreme-Temperature Zones in London in December
SMi Reports: Cold Chain Distribution 2015: Enhance Temperature Management for an Efficient Supply Chain. - October 24, 2015 - SAE Media Group
Human Factors Engineering in Pre-Filled Syringes to be Addressed by Amgen, MHRA, F.Hoffman-La Roche and Medical Device Usability at Pre-Filled Syringes 2016 in London
SMi Reports: Pre-Filled Syringes 2016: The A-Z Guide to develop a safe, patient-centric and commercially viable drug delivery device. - October 22, 2015 - SAE Media Group
Source One’s Data Scientist Brings the Future of Spend Management to Tomorrow's Business Leaders
Adding to an already jam-packed Quarter 4, noted Procurement Services Provider, Source One Management Services, LLC, continues its educational outreach with a speaking engagement at La Salle University. Source One Data Scientist, James Patounas will be the featured speaker at the October 2015... - October 20, 2015 - Source One, a Corcentric Company
Oak Street Health and Tabula Rasa Healthcare Aim to Improve Patient Outcomes Through Optimization of Medication Regimens
Program's goal is to improve the safety of patient medication regimens and patient outcomes using Tabula Rasa's novel and proprietary MRM technolgy platform in tandem with the automated, robotic dispensary of TRHC's CareKinesis Pharmacy. - October 15, 2015 - Tabula Rasa HealthCare
European Pre-Filled Syringes Market: Latest updates from GSK R&D, Sanofi R&D, Amgen, MHRA, F.Hoffmann-La Roche Ltd, Novartis Pharma AG, Barts Health Pharmaceuticals
SMi Reports (2015.10.13, London): Leading drug delivery experts will gather in London next January to discuss the upcoming obstacles and the solutions which can be explored to accelerate pre-filled syringes development and technology advancements. - October 15, 2015 - SAE Media Group
Gensco Laboratories Supports World Arthritis Day on October 12, 2015
Gensco Laboratories, a specialty pharmaceutical company, has recently introduced a new transdermal prescription medication that provides rapid relief at the first sign of an acute gout flare, ColciGel®, indicated for the treatment and prophylaxis of acute gout flares in adults. ColciGel® is easy to apply directly on the site of pain and each bottle has Metered Dose Technology (MDose™) which dispenses the exact amount of transdermal medication. - October 12, 2015 - Gensco Labs
CHI to Host Roundtable Discussions at Optimizing Bioassays for Biologics Conference
Moderated by Drs. Han Li, Bristol-Myers Squibb; Maura C. Kibbey, United States Pharmacopeia (USP); and Max L. Tejada, Gilead Sciences - October 10, 2015 - Cambridge Healthtech Institute
Visibility Magazine Along with SMi Group Announces - The Social Media Doctor: Pharmaceutical Industry Enters Into a New and Exciting Digital Era in 2016
Solidifying digital strategy to enhance patient engagement at SMi Group's 8th annual conference on Social Media in the Pharmaceutical Industry - October 09, 2015 - topseos.com
New Research Identifies Leading Clinical CROs Best Positioned for Future Success
New Research Identifies Future Leadership and Benchmarks CRO Operational Performance with over 160 Clinical Outsourcing Decision Makers - October 07, 2015 - Life Science Strategy Group, LLC
Recursion Pharma Receives Orphan Drug Designation for Hereditary Stroke Disorder
Recursion Pharmaceuticals, a drug discovery start-up company, announced receipt of an Orphan Drug Designation from the FDA for the use of Tempol for the treatment of Cerebral Cavernous Malformation, a hereditary stroke disease. Recursion expects this will be the first of many potential treatments identified using their proprietary drug discovery platform. - October 05, 2015 - Recursion Pharmaceuticals
23rd SAPA Annual Conference “Advancing Breakthrough Medicines Through Global Innovation and Partnership”
On September 12th, 2015, SAPA (Sino-American Pharmaceutical Professionals Association) hosted its 23rd Annual Conference at Princeton University, McDonnell Hall. The conference was a huge success and attracted around 500 experts and professionals from both Pharmaceutical and Biotech industry and... - October 01, 2015 - Sino-American Pharmaceutical Professionals Association
Ixogel® is Granted QIDP Status by the US Food and Drug Administration
Ixodes AG, a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention of Lyme Disease, today announced that the U.S. Food and Drug Administration (FDA) has designated the company's lead product candidate, Ixogel®, as a Qualified Infectious Disease Product (QIDP) for the prevention of Lyme Disease after a tick bite and is working with the company on the phase III protocol. Special Protocol Assessment (SPA) confirmation expected soon. - September 29, 2015 - Ixodes AG